Investors have done that in the past. That is what the series A-H pref shares were all about. What so many of you are over looking is that Amarantus hasn't "unlocked the potential" of any of their assets. The reason of the huge sell off is that those investors who were promised improvement and advancement of certain assets by the company started to balk at their investment when Amarantus didn't unlock anything. The sell offs we have witnessed over the last 4 months or so weren't because Amarantus was moving forward and hitting milestones but because it failed to do what the company told its investors it would accomplish. It is amazing that some on here like to say
"know what you own," but obviously you do not.

Another thing I'd love to know is what is the head count at Amarantus. They did a lot of hiring the last few years. How many of those people are still there?

And also remember, we heard of the search for a person to head the Diagnostics Department for a spin off to increase shareholder value to the pathetic dumping of it to another struggling OTC who itself has been sitting on a passed around diagnostic test for many years. Not so encouraging. But hey, you guys keep patting yourselfs on the back about all the thumbs up you are getting and how Gerald is going to finally turn this around while waiting for ESS sits waiting to get into trials.

In the mean time, the stock is down 99% from its high after a brutal 150 RS and promise of an uplisting, which didn't happen.